news

Two global biopharmaceutical companies join effort to address the growing non-communicable disease burden in low- and middle-income countries

GENEVA, SWITZERLAND – Today, Ipsen and Servier, two global biopharmaceutical companies, joined Access Accelerated, an initiative aimed at advancing access to non-communicable disease (NCD) prevention, treatment and care in low- and middle income countries (LMICs). Together with partners from across the global biopharmaceutical sector, multilateral organizations and non-governmental organizations, Access Accelerated works toward a future where no one dies prematurely from treatable, preventable diseases.Read More


Access Accelerated returned to Kenya from 28 February to 1 March for the non-communicable diseases (NCDs) stakeholder meeting, “Redefining UHC – the Opportunity for NCDs,” co-hosted with the Ministry of Health and NCD Alliance Kenya in Naivasha. With representation from the Kenyan government across ministries and attendees that spanned civil society, representatives from 12 Access Accelerated member companies, people living with NCDs (PLWNCDs) and government officials from six African nations, the meeting provided a forum to reflect on progress made and recommit to increasing access to NCD treatment and care in the context of the country’s push toward Universal Health Coverage (UHC).
Read More


Cancer mortality rates in children show unacceptable inequalities between high and low- and middle-income countries. In the latter, late diagnosis, inadequate access to healthcare facilities, and treatment abandonment are the main hurdles for remission. For over 12 years, My Child Matters program has funded 58 cancer projects in more than 40 low- and middle-income countries, reaching so far over 85,000 children. The goal of this initiative, developed by the Fondation Sanofi Espoir, aims to bring equity so that all children with cancer will have the same chance to heal wherever they are in the world.Read More

This article presents the results of a pilot evaluation on diabetes knowledge and behavior of caregivers and school staff of providing education on diabetes in a school setting. The intervention is based on an educational package co-created by the International Diabetes Federation (IDF), the International Society for Pediatric and Adolescent Diabetes (ISPAD), local partners and Sanofi.
Read More

NCDA Kenya (NCDAK) and NCD Alliance held a workshop on 21-22 March to develop The Advocacy Agenda of People living with NCDs (PLWNCDs) in Kenya. The meeting aimed to consult with PLWNCDs to define a common Advocacy Agenda, explore communications and advocacy needed to further the agenda, and promote among stakeholders meaningful involvement of PLWNCDs.Read More

This article describes the cancer registry in Colombia, VIGICANCER, supported by Sanofi Espoir Foundation through its My Child Matters program since 2009. From 2009 to 2013, data from 1242 patients were included in Vigicancer. This study demonstrates the feasibility of implementing a real-time childhood cancer outcomes surveillance system, that can guide interventions to improve clinical outcomes in LMICs.
Read More

This article describes the experience of the pediatric oncology team from Bamako (Mali) in the Retinoblastoma program, supported by Sanofi Espoir Foundation through the My Child Matters program. A prospective study in children with retinoblastoma demonstrates that early enucleation in early stage of tumor can improve outcomes in resources-limited countries.
Read More